All articles by Surya Rao Akella

Surya Rao Akella

Advanced Medical acquires Sealantis for $25m

Advanced Medical will pay an initial consideration of $25m in cash, to be funded from existing cash resources, which were £71m…

Philips, MIM Software partner to enhance radiation therapy treatment planning

Under the collaboration, Phillips and MIM Software will integrate their radiation oncology solutions to allow clinicians benefit from a streamlined…

Charles River expands genetic toxicology assays portfolio through Toxys partnership

ToxTracker from Toxys allows for rapid carcinogenicity toxicity hazard identification in new and existing drugs, chemicals and other substances. The…

World’s first prostate cancer surgery performed using Isoray’s brachytherapy system

Isoray stated that its disposable, single use, brachytherapy system has been designed to be handheld, offering a new level of…

Southern Spine announces three new StabiLink Dual Lamina implants

Alan H. Daniels MD, Associate Professor of Orthopaedic Surgery at The Warren Alpert Medical School of Brown University has specifically…

Senseonics Eversense CGM Sensor receives indication for MRI

“Based on our testing, we have demonstrated that it is safe for patients to leave the Eversense Sensor in place,…

Medtronic announces positive results for NAVIGATE study in lung cancer diagnosis

Medtronic stated that its NAVIGATE study included a key finding where 65% of patients diagnosed with primary lung cancer were…

Study suggests Surgical Stapler may play key role in reducing common complication associated with lung surgery

The research was funded by Ethicon, part of Johnson & Johnson Medical Devices Companies, and is being announced this week…

BrainsWay receives PMDA approval in Japan of deep transcranial magnetic stimulation system

The PMDA approval was obtained in collaboration with BrainsWay’s exclusive distributor in Japan, Century Medical, Inc. (CMI), an ITOCHU Group…

Neovasc receives approval in Germany, UK to begin phase 2 of Tiara-II study

Neovasc, the US-based developer of minimally invasive transcatheter mitral valve replacement technologies, has stated that it has recently completed the…